School of Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Mol Pharm. 2011 Aug 1;8(4):1100-12. doi: 10.1021/mp1004178. Epub 2011 May 27.
With an ever increasing number of particulate drug delivery systems being developed for the intracellular delivery of therapeutics a robust high-throughput method for studying particle-cell interactions is urgently required. Current methods used for analyzing particle-cell interaction include spectrofluorimetry, flow cytometry, and fluorescence/confocal microscopy, but these methods are not high throughput and provide only limited data on the specific number of particles delivered intracellularly to the target cell. The work herein presents an automated high-throughput method to analyze microparticulate drug delivery system (DDS) uptake byalveolar macrophages. Poly(lactic-co-glycolic acid) (PLGA) microparticles were prepared in a range of sizes using a solvent evaporation method. A human monocyte cell line (THP-1) was differentiated into macrophage like cells using phorbol 12-myristate 13-acetate (PMA), and cells were treated with microparticles for 1 h and studied using confocal laser scanning microscopy (CLSM), spectrofluorimetry and a high-content analysis (HCA). PLGA microparticles within the size range of 0.8-2.1 μm were found to be optimal for macrophage targeting (p < 0.05). Uptake studies carried out at 37 °C and 4 °C indicated that microparticles were internalized in an energy dependent manner. To improve particle uptake, a range of opsonic coatings were assessed. Coating PLGA particles with gelatin and ovalbumin was found to significantly increase particle uptake from 2.75 ± 0.98 particles per cell for particles coated with gelatin. Opsonic coating also significantly increased particle internalization into primary human alveolar macrophages (p < 0.01) with a 1.7-fold increase in uptake from 4.19 ± 0.48 for uncoated to 7.53 ± 0.88 particles per cell for coated particles. In comparison to techniques such as spectrofluorimetry and CLSM, HCA provides both qualitative and quantitative data on the influence of carrier design on cell targeting that can be gathered in a high-throughput format and therefore has great potential in the screening of intracellularly targeted DDS.
随着越来越多的用于细胞内递药的微粒药物传递系统被开发出来,人们迫切需要一种强大的高通量方法来研究颗粒与细胞的相互作用。目前用于分析颗粒与细胞相互作用的方法包括荧光分光光度法、流式细胞术和荧光/共聚焦显微镜,但这些方法不是高通量的,只能提供关于特定数量的颗粒递送到靶细胞内的有限数据。本文介绍了一种自动化高通量方法,用于分析肺泡巨噬细胞对微粒药物传递系统(DDS)的摄取。使用溶剂蒸发法制备了一系列不同大小的聚(乳酸-共-乙醇酸)(PLGA)微粒。用人单核细胞系(THP-1)用佛波醇 12-肉豆蔻酸 13-乙酸酯(PMA)分化为巨噬细胞样细胞,然后用微粒处理细胞 1 小时,并使用共聚焦激光扫描显微镜(CLSM)、荧光分光光度法和高内涵分析(HCA)进行研究。发现粒径在 0.8-2.1 μm 范围内的 PLGA 微粒最适合巨噬细胞靶向(p < 0.05)。在 37°C 和 4°C 进行的摄取研究表明,微粒以能量依赖的方式被内化。为了提高颗粒的摄取,评估了一系列调理涂层。发现用明胶和卵清蛋白对 PLGA 颗粒进行调理涂层可显著增加颗粒的摄取,从用明胶涂层的颗粒每细胞 2.75 ± 0.98 个颗粒增加到 7.53 ± 0.88 个颗粒。调理涂层还显著增加了颗粒进入原代人肺泡巨噬细胞的内化(p < 0.01),摄取量从未涂层的 4.19 ± 0.48 个颗粒增加到涂层的 7.53 ± 0.88 个颗粒。与荧光分光光度法和 CLSM 等技术相比,HCA 提供了关于载体设计对细胞靶向的影响的定性和定量数据,可以以高通量的格式收集,因此在筛选细胞内靶向 DDS 方面具有很大的潜力。